News June 3, 2019 BIO Preview: Some of the Highlights of One of the World’s Premier Life Science Conventions | BioSpace The BIO International Convention is being held in Philadelphia from June 3-6, with more than… Super User 0 Love0
News June 3, 2019 Tick tock: Register now, 2019 Technology Showcase June 12, 2019! Register now for the 3rd annual Technology Showcase! The 2019 Technology Showcase will… Super User 0 Love0
News June 3, 2019 Johns Hopkins founded and BHCR Crab Trap Winner medical research firm LifeSprout gets financing boost – Baltimore Sun A Baltimore-based regenerative medicine firm called LifeSprout, which makes synthetic products used to restore soft… Super User 0 Love0
News June 3, 2019 Baltimore firm raises $110 million to bring Johns Hopkins’ cancer-detecting blood test to market – Baltimore Sun A newly formed Baltimore company has raised $110 million to commercialize a cancer-detecting blood test,… Super User 0 Love0
News June 3, 2019 QIAGEN launches first FDA-approved companion diagnostic for PIK3CA biomarkers to enhance precision medicine in breast cancer QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the immediate launch of its therascreen®… Super User 0 Love0
News June 3, 2019 With FDA Approval Of Zolgensma, Regenxbio Sets Out For First Revenue Stream – REGENXBIO Inc. (NASDAQ:RGNX) | Seeking Alpha Regenxbio (RGNX) announced that a gene therapy developed based on its technology was approved by… Super User 0 Love0
News June 3, 2019 NHLBI Funding & Research Opportunities and Announcements for May 3, 2019 Funding and Research Opportunities The following funding opportunity announcements from the NHLBI or other components of… Super User 0 Love0
News June 3, 2019 Gaithersburg’s Viela Bio strikes $220M partnership with Hansoh Pharmaceutical Group – Washington Business Journal It's the local company's first step toward establishing an international presence after it was spun… Super User 0 Love0
News June 3, 2019 Rexahn Announces Move to Nasdaq – Rexahn Pharmaceuticals, Inc. Rexahn Pharmaceuticals, Inc. (NYSE American: RNN), a clinical stage biopharmaceutical company developing innovative therapies to… Super User 0 Love0